Youn J. Moon

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Plasma extracellular vesicle-associated miR-512-3p modulates angiogenesis in pediatric Moyamoya disease by targeting ARHGEF3.

Plasma extracellular vesicle-associated miR-512-3p modulates angiogenesis in pediatric Moyamoya disease by targeting ARHGEF3.

Journal: Scientific reports

Published: December 02, 2024

Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.

Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.

Journal: Journal of Korean Neurosurgical Society

Published: January 06, 2023

Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.

Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: December 05, 2018

Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker.

Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker.

Journal: Journal of stroke

Published: April 06, 2018

Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.

Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.

Journal: Journal of neurosurgery. Pediatrics

Published: February 06, 2018

Mitochondrial abnormalities related to the dysfunction of circulating endothelial colony-forming cells in moyamoya disease.

Mitochondrial abnormalities related to the dysfunction of circulating endothelial colony-forming cells in moyamoya disease.

Journal: Journal of neurosurgery

Published: January 16, 2017

Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.

Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.

Journal: PloS one

Published: September 17, 2016

Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.

Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.

Journal: Journal of neurosurgery. Pediatrics

Published: February 06, 2016

Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.

Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 28, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026